Olumiant Approved for COVID-19 Treatment in Hospitalized Adults
The FDA has approved Olumiant (baricitinib) for the treatment of COVID-19 in certain hospitalized adults.
Source: cancertherapyadvisor.com
📰 Kaplan Meier News
Page 6 - Kaplan Meier News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kaplan Meier. Real-time updates on events, politics, business and more.
UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Developments
UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Developments - read this article along with other careers information, tips and advice on BioSpace
United States Kaplan Meier Liz Barrett Urogen Pharma University Of Texas Md Anderson Cancer Center Urogen Ltd
Source: biospace.com
Chromogranin A plasma levels increase in COVID - predict mortality
A recent paper posted to the Public Library of Science (PLOS) ONE journal showed that plasma levels of chromogranin A (CgA) could predict death in coronavirus disease 2019 (COVID-19) patients.
Kaplan Meier Public Library Of Science Public Library Coronavirus Disease Covid 19 Diabetes Mellitus Heart Failure
Source: news-medical.net
Greenwich LifeSciences Stock: Insider Buying And Buybacks
Greenwich LifeSciences became public in Sept. 2020. See why I view GLSI as a Buy on weakness or a Hold, but only for those with an above-average risk tolerance.
United States Kaplan Meier Snehal Patel Clinical Affairs American Association For Cancer Research Buyback Program And Skin
Source: seekingalpha.com
Adult patients diagnosed with selected solid malignancies
To investigate the treatment outcomes and its determinant factors among adult patients diagnosed with selected solid malignancies at Kenyatta National Hospital.
United States Kaplan Meier United States International University European Organization For Research Oncology Department Oncology Department Of Kenyatta National Hospital
Source: dovepress.com
Study on the viral dynamics of Omicron and Delta infected individuals
Researchers examine the infectious periods in vaccinated individuals infected with the SARS-CoV-2 Omicron and Delta variants.
Kaplan Meier Goodstudio Shutterstock Boston University School Of Medicine Boston University Boston University School Coronavirus Disease Covid 19
Source: news-medical.net
Sequana Medical NV: Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study
Reporting of primary endpoint on track for Q4 2022FDA regulatory submission on track for mid-202370% survival of POSEIDON Roll-In patients at one year post-implantation1 compares favourably
Source: finanznachrichten.de
Sequana Medical announces the completion of alfapump
Reporting of primary endpoint on track for Q4 2022FDA regulatory submission on track for mid-202370% survival of POSEIDON Roll-In patients at one year...
Source: globenewswire.com
Sequana Medical Announces the Completion of alfapump
Reporting of primary endpoint on track for Q4 2022FDA regulatory submission on track for mid-202370% survival of POSEIDON Roll-In patients at one year...
Source: globenewswire.com
Esophageal Cancer: RFA Has Long-Lasting Protective Effects
A 10-year report from the United Kingdom shows the benefits are durable for patients with Barretts esophagus.
United States United Kingdom Shria Kumar Paul Wolfson University College London Division Of Digestive
Source: medscape.com